Home › Psoriatic Arthritis › Ohio › Cleveland
Psoriatic Arthritis clinical trials in Cleveland, OH
3 studies for Psoriatic Arthritis are looking for participants at sites in and around Cleveland (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
RecruitingObservational study
- Metrohealth Medical Center, Cleveland
- Cleveland Clinic Foundation, Cleveland
A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
RecruitingPhase 3
- MetroHealth Medical Center /ID# 262377, Cleveland
- Cleveland Clinic - Cleveland /ID# 276655, Cleveland
A Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic Arthritis
RecruitingPhase 4
- University Hospitals Cleveland Medical Center, Cleveland
About Psoriatic Arthritis
Psoriasis is a skin disease that causes itchy or sore patches of thick, red skin with silvery scales. Find out about symptoms and treatment.
More about Psoriatic Arthritis on MedlinePlus
Psoriatic Arthritis trials in other cities
- Houston, TX5 studies
- Durham, NC4 studies
- Milwaukee, WI4 studies
- New York City, NY4 studies
- Dallas, TX3 studies
- Washington, DC3 studies
- Boston, MA3 studies
- San Diego, CA3 studies
- Columbus, OH3 studies
- Charlotte, NC3 studies
- Orlando, FL3 studies
- Philadelphia, PA3 studies
Other studies in Cleveland
- Non-Small Cell Lung Cancer48 studies
- Cancer (all types)36 studies
- Breast Cancer33 studies
- Heart Failure31 studies
- Metastatic Cancer30 studies
- Prostate Cancer30 studies
- Ovarian Cancer29 studies
- Lung Cancer26 studies
- Colorectal Cancer25 studies
- Acute Myeloid Leukemia20 studies
- Head and Neck Squamous Cell Carcinoma20 studies
- Cardiovascular Disease20 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.